Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 25
Filter
1.
Am J Trop Med Hyg ; 99(5): 1291-1293, 2018 11.
Article in English | MEDLINE | ID: mdl-30334519

ABSTRACT

Dengue encephalitis and dengue encephalopathy are frequent neurological complications of systemic dengue virus infection. Neuroimaging is normal in approximately 50% of patients. Common imaging abnormalities involve periventricular structures, including the basal ganglion, thalamus, and periventricular white matter. We describe an unusual case of dengue encephalopathy with unilateral imaging abnormalities involving the right cerebral hemisphere and mimicking the involvement of the right middle cerebral artery.


Subject(s)
Brain Diseases/diagnostic imaging , Brain/diagnostic imaging , Brain/pathology , Dengue/complications , Neuroimaging , Adult , Brain/virology , Brain Diseases/virology , Cerebral Ventricles/pathology , Cerebral Ventricles/virology , Dengue/drug therapy , Fever/complications , Folic Acid/therapeutic use , Humans , Magnetic Resonance Imaging , Male , Tomography, X-Ray Computed , Treatment Outcome , Vitamin B 12/therapeutic use
2.
Article in English, Russian | MEDLINE | ID: mdl-27500777

ABSTRACT

Substantiation of the shunt failure diagnosis and subsequent consideration of indications for surgical elimination of the malfunction is a laborious and challenging process. Identification of a malfunction in doubtful cases requires, in addition to standard examinations, extra diagnostic procedures, which may delay making a decision for several weeks to several months. The article describes a case of mechanical CSF shunt malfunction (breakage and failure of a peritoneal catheter in a 7-year-old girl) with intracranial hypertension symptoms, but without typical enlargement of the brain ventricles. According to the medical history, congenital hydrocephalus in the child was accompanied by an inflammatory process of bacterial and viral etiology. The absence of brain ventricle enlargement was shown not to exclude a probability of shunt malfunction. In this case, a specific phenomenon, an intraparenchymatous cerebrospinal fluid "lake" surrounding a ventricular catheter, was observed. Shunting recovery did not lead to a significant reduction in the phenomenon size. Causes underlying this phenomenon require further investigation.


Subject(s)
Cerebral Ventricles/surgery , Cerebrospinal Fluid Shunts , Hydrocephalus/physiopathology , Intracranial Hypertension/surgery , Cerebral Ventricles/microbiology , Cerebral Ventricles/physiopathology , Cerebral Ventricles/virology , Cerebrospinal Fluid Shunts/adverse effects , Child , Cytomegalovirus/isolation & purification , Cytomegalovirus/pathogenicity , Cytomegalovirus Infections/cerebrospinal fluid , Cytomegalovirus Infections/complications , Cytomegalovirus Infections/microbiology , Cytomegalovirus Infections/virology , Female , Humans , Hydrocephalus/complications , Hydrocephalus/microbiology , Hydrocephalus/virology , Intracranial Hypertension/physiopathology , Streptococcal Infections/cerebrospinal fluid , Streptococcal Infections/complications , Streptococcal Infections/microbiology , Streptococcal Infections/virology , Streptococcus pyogenes/isolation & purification , Streptococcus pyogenes/pathogenicity
4.
Mol Ther ; 19(5): 860-9, 2011 May.
Article in English | MEDLINE | ID: mdl-21326216

ABSTRACT

Multiple sulfatase deficiency (MSD), a severe autosomal recessive disease is caused by mutations in the sulfatase modifying factor 1 gene (Sumf1). We have previously shown that in the Sumf1 knockout mouse model (Sumf1(-/-)) sulfatase activities are completely absent and, similarly to MSD patients, this mouse model displays growth retardation and early mortality. The severity of the phenotype makes MSD unsuitable to be treated by enzyme replacement or bone marrow transplantation, hence the importance of testing the efficacy of novel treatment strategies. Here we show that recombinant adeno-associated virus serotype 9 (rAAV9) vector injected into the cerebral ventricles of neonatal mice resulted in efficient and widespread transduction of the brain parenchyma. In addition, we compared a combined, intracerebral ventricles and systemic, administration of an rAAV9 vector encoding SUMF1 gene to the single administrations-either directly in brain, or systemic alone -in MSD mice. The combined treatment resulted in the global activation of sulfatases, near-complete clearance of glycosaminoglycans (GAGs) and decrease of inflammation in both the central nervous system (CNS) and visceral organs. Furthermore, behavioral abilities were improved by the combined treatment. These results underscore that the "combined" mode of rAAV9 vector administration is an efficient option for the treatment of severe whole-body disorders.


Subject(s)
Genetic Therapy , Multiple Sulfatase Deficiency Disease/genetics , Multiple Sulfatase Deficiency Disease/therapy , Sulfatases/metabolism , Animals , Blotting, Western , Central Nervous System/immunology , Central Nervous System/pathology , Cerebral Ventricles/virology , Dependovirus/genetics , Disease Models, Animal , Fluorescent Antibody Technique , Gene Transfer Techniques , Genes, Transgenic, Suicide , Genetic Vectors , Glycosaminoglycans/metabolism , Inflammation/therapy , Mice , Mice, Inbred C57BL , Oxidoreductases Acting on Sulfur Group Donors , Sulfatases/deficiency
6.
PLoS One ; 4(12): e8134, 2009 Dec 02.
Article in English | MEDLINE | ID: mdl-19956550

ABSTRACT

BACKGROUND: The low immunogenicity of neural stem/progenitor cells (NSPCs) coupled with negligible expression of MHC antigens has popularized their use in transplantation medicine. However, in an inflammatory environment, the NSPCs express costimulatory molecules and MHC antigens, and also exhibit certain immunomodulatory functions. Since NSPCs are the cellular targets in a number of virus infections both during postnatal and adult stages, we wanted to investigate the immunological properties of these stem cells in response to viral pathogen. METHODOLOGY/PRINCIPAL FINDINGS: We utilized both in vivo mouse model and in vitro neurosphere model of Japanese encephalitis virus (JEV) infection for the study. The NSPCs residing in the subventricular zone of the infected brains showed prominent expression of MHC-I and costimulatory molecules CD40, CD80, and CD86. Using Flow cytometry and fluorescence microscopy, we observed increased surface expression of co-stimulatory molecule and MHC class I antigen in NSPCs upon progressive JEV infection in vitro. Moreover, significant production of pro-inflammatory cyto/chemokines was detected in JEV infected NSPCs by Cytokine Bead Array analysis. Interestingly, NSPCs were capable of providing functional costimulation to allogenic T cells and JEV infection resulted in increased proliferation of allogenic T cells, as detected by Mixed Lymphocyte reaction and CFSE experiments. We also report IL-2 production by NSPCs upon JEV infection, which possibly provides mitogenic signals to T cells and trigger their proliferation. CONCLUSION/SIGNIFICANCE: The in vivo and in vitro findings clearly indicate the development of immunogenicity in NSPCs following progressive JEV infection, in our case, JEV infection. Following a neurotropic virus infection, NSPCs possibly behave as immunogenic cells and contribute to both the innate and adaptive immune axes. The newly discovered immunological properties of NSPCs may have implications in assigning a new role of these cells as non-professional antigen presenting cells in the central nervous system.


Subject(s)
Encephalitis Virus, Japanese/immunology , Immunocompetence/immunology , Neurons/cytology , Neurons/immunology , Stem Cells/immunology , Stem Cells/virology , Animals , Cell Proliferation , Cerebral Ventricles/immunology , Cerebral Ventricles/pathology , Cerebral Ventricles/virology , Disease Progression , Encephalitis, Japanese/immunology , Encephalitis, Japanese/pathology , Encephalitis, Japanese/virology , Histocompatibility Antigens Class I/immunology , Interleukin-2/genetics , Interleukin-2/metabolism , Mice , Mice, Inbred BALB C , Neurons/virology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Stem Cells/cytology , T-Lymphocytes/cytology , T-Lymphocytes/immunology , T-Lymphocytes/virology , Up-Regulation/genetics
7.
Curr HIV Res ; 5(2): 267-72, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17346140

ABSTRACT

In this paper we report the study of tryptophan metabolism via serotonin in ventricular CSF in HIV-1 infection in order to investigate the origin of tryptophan metabolites in the human brain. The patients (n=4) were affected with non-communicating hydrocephalus. One of these also was suffering from HIV-1 infection. The CSF was withdrawn from different sites of the cerebral cavity with a neuroendoscopic procedure which allows an accurate exploration of all the cerebral ventricles. The measurement of tryptophan, 5-hydroxytryptophan, serotonin, 5-hydroxyindoleacetic acid, and melatonin was carried out by HPLC with fluorometric detection. In HIV-1 infection the highest concentration of tryptophan is present in the CSF of the choroid plexus; however, the levels are markedly lower than those in hydrocephalic individuals (control group). 5-Hydroxytryptophan CSF content is higher in HIV-1 infection than in hydrocephalic controls in all districts examined. Regarding serotonin, a great difference appears in the choroid plexus and in the pituitary recess between the HIV-1 infected patient and the control group. The values of 5-hydroxyindoleacetic acid are much lower in the CSF of the HIV-1 infected patient than in hydrocephalic controls. Melatonin levels appear to fluctuate largely but, in the HIV-1 infection, a great variability is present among the sites of CSF withdrawal. The third ventricle contains the highest concentration of melatonin and the choroid plexus and the pituitary recess the lowest. All the melatonin concentrations in HIV-1 infection are largely different than in hydrocephalic controls. This is the first report on the measurement of tryptophan metabolites via serotonin in ventricular CSF in HIV-1 infection.


Subject(s)
Cerebral Ventricles/metabolism , HIV Infections/cerebrospinal fluid , HIV-1/pathogenicity , Hydrocephalus/cerebrospinal fluid , Serotonin/metabolism , Tryptophan/metabolism , 5-Hydroxytryptophan/cerebrospinal fluid , Adult , Aged , Cerebral Ventricles/virology , Endoscopy , HIV-1/metabolism , Humans , Hydroxyindoleacetic Acid/cerebrospinal fluid , Male , Melatonin/cerebrospinal fluid , Serotonin/cerebrospinal fluid , Tryptophan/cerebrospinal fluid , Ventriculostomy
8.
Brain Res ; 1122(1): 1-9, 2006 Nov 29.
Article in English | MEDLINE | ID: mdl-17045577

ABSTRACT

Most gene transfer studies conducted in the central nervous system (CNS) with recombinant adeno-associated virus (rAAV) vectors have been carried out by direct intra-parenchymal injection. However, this delivery method usually results in transduction of cells in only a limited region and is quite invasive, which may hamper its potential clinical application. Injection of viral vectors into the cerebrospinal fluid (CSF) may provide an alternative strategy for widespread gene delivery to the CNS via the subarachnoid space. In this study we compared the transduction abilities of rAAV types 1, 2, and 5 when infused directly into the right lateral cerebral ventricle of adult rats. Multiple structures in the vicinity of the lateral ventricle were transduced by rAAV1, but not by rAAV2 or rAAV5 vectors. Double immunolabeling showed that the transduced cells included not only neurons, but also glia. Real-time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) experiments demonstrated that rAAV1-mediated EGFP mRNA expression was significantly higher than that induced by either rAAV2 or 5. Our data suggest that intra-ventricular infusion of rAAV1 vectors provides a useful method for broad gene delivery to cells in the adult rat CNS.


Subject(s)
Brain/metabolism , Dependovirus/genetics , Genetic Vectors/genetics , Green Fluorescent Proteins/biosynthesis , Transduction, Genetic/methods , Animals , Brain/cytology , Brain/virology , Cerebral Ventricles/virology , Dependovirus/classification , Genetic Engineering/methods , Genetic Vectors/classification , Green Fluorescent Proteins/genetics , Injections, Intraventricular , Male , Neuroglia/metabolism , Neuroglia/virology , Neurons/metabolism , Neurons/virology , RNA, Messenger/analysis , Rats , Rats, Sprague-Dawley , Tissue Distribution
9.
Neurosci Lett ; 393(2-3): 102-7, 2006 Jan 30.
Article in English | MEDLINE | ID: mdl-16229949

ABSTRACT

In the central nervous system (CNS), HIV-1 targets mainly microglia/macrophages. Like the CD4+ T cell depletion and neuronal loss in AIDS, apoptosis is thought to be involved in eliminating infected macrophages. In this study, we examined the expression of the pro-apoptotic BH3-peptide harakiri (Hrk) in brain tissues of AIDS patients. Immunoreactivity against Hrk was positive in perivascular macrophages infiltrated into some restricted lesions. Most of these immunopositive cells contained small inclusions positive for Grocott's methenamine silver staining. Confocal laser microscopy demonstrated that Hrk expression coincided with immunoreactivities against HIV-1 and Cryptococcus neoformans. Expression of Hrk mRNA was demonstrated in these cells by in situ hybridization, which indicated that Hrk is not phagocytosed material. Some pro-apoptotic bcl-family members, including Hrk, may contribute to the delayed hypersensitive reaction in AIDS, in macrophages eliminating opportunistic infection.


Subject(s)
Cerebral Ventricles/pathology , Cryptococcus neoformans , Encephalitis/pathology , HIV Infections/pathology , Macrophages/metabolism , Neuropeptides/metabolism , Adult , Aged , Aged, 80 and over , Apoptosis Regulatory Proteins , Brain/metabolism , Brain/pathology , Cerebral Ventricles/virology , Encephalitis/complications , Encephalitis/metabolism , Encephalitis/virology , Female , HIV Core Protein p24/metabolism , HIV Infections/complications , HIV Infections/metabolism , HLA-DR Antigens/metabolism , Humans , Immunohistochemistry/methods , In Situ Hybridization/methods , Male , Middle Aged , Neuropeptides/genetics , RNA, Messenger/metabolism , Silver Staining/methods
10.
Mov Disord ; 21(4): 564-6, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16250020

ABSTRACT

A 10-year-old boy presented with fever, headache, vomiting, and hypersomnolence. An akinetic-rigid syndrome with tremor, dysphagia, dysphonia, and sialorrhea, as well as pyramidal signs, developed. Slightly elevated protein content was found in the cerebrospinal fluid and serological investigations were suggestive of a primary Epstein-Barr virus infection. Magnetic resonance imaging (MRI) showed massive bilateral hyperintense striatal and punctiform periventricular lesions. After 2-month treatment with steroids and antiparkinsonian drugs, all features resolved without sequelae. Control MRI demonstrated only minimal residual lesions in both putamina. Strongly resembling the encephalitis lethargica-like syndrome, this case is an unusual presentation of parainfectious acute disseminated encephalitis.


Subject(s)
Encephalitis, Viral/complications , Epstein-Barr Virus Infections/complications , Parkinsonian Disorders/etiology , Parkinsonian Disorders/virology , Antiparkinson Agents/therapeutic use , Cerebral Ventricles/drug effects , Cerebral Ventricles/pathology , Cerebral Ventricles/virology , Child , Corpus Striatum/drug effects , Corpus Striatum/pathology , Corpus Striatum/virology , Encephalitis, Viral/drug therapy , Encephalitis, Viral/pathology , Epstein-Barr Virus Infections/drug therapy , Epstein-Barr Virus Infections/pathology , Humans , Magnetic Resonance Imaging/methods , Male , Parkinsonian Disorders/drug therapy , Parkinsonian Disorders/pathology , Steroids/therapeutic use
12.
J Neurosci ; 25(9): 2434-44, 2005 Mar 02.
Article in English | MEDLINE | ID: mdl-15745971

ABSTRACT

Type B coxsackieviruses (CVB) frequently infect the CNS and, together with other enteroviruses, are the most common cause of viral meningitis in humans. Newborn infants are particularly vulnerable, and CVB also can infect the fetus, leading to mortality, or to neurodevelopmental defects in surviving infants. Using a mouse model of neonatal CVB infection, we previously demonstrated that coxsackievirus B3 (CVB3) could infect neuronal progenitor cells in the subventricular zone (SVZ). Here we extend these findings, and we show that CVB3 targets actively proliferating (bromodeoxyuridine+, Ki67+) cells in the SVZ, including type B and type A stem cells. However, infected cells exiting the SVZ have lost their proliferative capacity, in contrast to their uninfected companions. Despite being proliferation deficient, the infected neuronal precursors could migrate along the rostral migratory stream and radial glia, to reach their final destinations in the olfactory bulb or cerebral cortex. Furthermore, infection did not prevent cell differentiation, as determined by cellular morphology and the expression of maturation markers. These data lead us to propose a model of CVB infection of the developing CNS, which may explain the neurodevelopmental defects that result from fetal infection.


Subject(s)
Cell Proliferation , Central Nervous System/pathology , Coxsackievirus Infections/pathology , Enterovirus B, Human/pathogenicity , Neurons/virology , Stem Cells/virology , Animals , Animals, Newborn , Bromodeoxyuridine/metabolism , Cell Count/methods , Central Nervous System/growth & development , Central Nervous System/metabolism , Central Nervous System/virology , Cerebral Ventricles/cytology , Cerebral Ventricles/metabolism , Cerebral Ventricles/virology , Coxsackievirus Infections/metabolism , Coxsackievirus Infections/physiopathology , Coxsackievirus Infections/virology , Disease Models, Animal , Enterovirus B, Human/genetics , Fluorescent Antibody Technique/methods , Green Fluorescent Proteins/metabolism , In Situ Hybridization/methods , Indoles/metabolism , Intermediate Filament Proteins/metabolism , Ki-67 Antigen/metabolism , Mice , Mice, Inbred BALB C , Nerve Tissue Proteins/metabolism , Nestin , Neural Cell Adhesion Molecule L1/metabolism , Neurons/physiology , Phosphopyruvate Hydratase/metabolism , Receptors, Virus/genetics , Receptors, Virus/metabolism , Sialic Acids/metabolism , Stem Cells/physiology , Tubulin/metabolism
15.
Prenat Diagn ; 22(7): 558-61, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12124687

ABSTRACT

Cytomegalovirus (CMV) is the leading infectious cause of prenatal neurological damage, which is particularly severe when primary maternal infection occurs during the first 16 weeks of gestation, at the time of organ development and neuronal migration. Vascular involvement has been suggested to be among the possible pathogenic mechanisms of virus-induced pathology, in addition to direct viral effects. We report on a fetus with cerebral CMV infection, which had intraventricular haemorrhage, together with oligohydramnios and hyperechogenic bowel, following maternal primary CMV infection.


Subject(s)
Cerebral Ventricles/abnormalities , Cytomegalovirus Infections/complications , Fetal Diseases/etiology , Intracranial Hemorrhages/etiology , Pregnancy Complications, Infectious , Abnormalities, Multiple/etiology , Abnormalities, Multiple/pathology , Adult , Cerebral Ventricles/diagnostic imaging , Cerebral Ventricles/virology , Cytomegalovirus/genetics , Cytomegalovirus/immunology , Cytomegalovirus/isolation & purification , Cytomegalovirus Infections/physiopathology , DNA, Viral/analysis , Female , Fetal Diseases/pathology , Humans , Infectious Disease Transmission, Vertical , Intestinal Diseases/diagnostic imaging , Intestinal Diseases/etiology , Intestines/abnormalities , Intestines/diagnostic imaging , Intracranial Hemorrhages/pathology , Oligohydramnios/etiology , Oligohydramnios/pathology , Polymerase Chain Reaction , Pregnancy , Pregnancy Trimester, First , Ultrasonography, Prenatal
16.
J Gen Virol ; 83(Pt 7): 1735-1743, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12075093

ABSTRACT

Non-neuroadapted influenza virus confined to the brain parenchyma does not induce antigen-specific immunity. Nevertheless, infection in this site upregulated major histocompatibility complex (MHC) class I and MHC class II expression and recruited lymphocytes to a perivascular compartment. T cells recovered from the brain had an activated/memory phenotype but did not respond to viral antigens. In contrast, T cells recovered from the brain after infection in a lateral cerebral ventricle, which is immunogenic, showed virus-specific responses. As with infectious virus, influenza virus-infected dendritic cells elicited virus-specific immunity when inoculated into the cerebrospinal fluid but not when inoculated into the brain parenchyma. Thus, inflammation and dendritic cell function were both uncoupled from immune priming in the microenvironment of the brain parenchyma and neither was sufficient to overcome immunological privilege.


Subject(s)
Brain/virology , Orthomyxoviridae Infections/immunology , Orthomyxoviridae/immunology , Animals , Antigens, CD/analysis , Brain/blood supply , Brain/immunology , Cerebral Ventricles/virology , Dendritic Cells/immunology , Dendritic Cells/virology , Inflammation/immunology , Major Histocompatibility Complex/immunology , Mice , Mice, Inbred C57BL , Orthomyxoviridae Infections/virology , Spleen/immunology , T-Lymphocytes/immunology
17.
Mol Ther ; 4(6): 603-13, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11735345

ABSTRACT

The possibility of inadvertent exposure of gonadal tissue to gene therapy vectors has raised safety concerns about germline infection. We show here that the receptor for coxsackie B viruses and adenoviruses 2 and 5 (CXADR) is expressed in mouse germ cells, suggesting the possibility that these viruses could infect germ cells. To directly assess the risk of germline infection in vivo, we injected an adenovirus carrying the germ-cell-specific protamine promoter fused to the bacterial lacZ reporter gene into the left ventricular cavity of mice and then monitored expression of the reporter gene in germ cells. To differentiate between infection of stem cells and differentiating spermatogenic cells, we analyzed expression of the reporter cassette at different times after viral delivery. Under all conditions tested, mice did not express the Escherichia coli beta-galactosidase protein in developing spermatids or in mature epididymal spermatozoa. Primary germ cells cultured in vitro were also refractory to adenoviral infection. Our data suggest that the chance of vertical germline transmission and insertional mutagenesis is highly unlikely following intracoronary adenoviral delivery.


Subject(s)
Adenoviridae/physiology , Cerebral Ventricles/virology , Genetic Therapy/methods , Receptors, Virus/metabolism , Spermatozoa/virology , Testis/virology , Animals , Coxsackie and Adenovirus Receptor-Like Membrane Protein , DNA Primers/chemistry , Fluorescent Antibody Technique, Indirect , Gene Transfer Techniques , Humans , Injections, Intraventricular , Lac Operon , Male , Membrane Proteins/genetics , Mice , Polymerase Chain Reaction , Spermatozoa/metabolism , Testis/metabolism , beta-Galactosidase/metabolism
18.
Clin Infect Dis ; 33(9): e105-8, 2001 Nov 01.
Article in English | MEDLINE | ID: mdl-11577375

ABSTRACT

We describe a case of CMV ventriculoencephalitis in a severely immunocompromised bone marrow transplant recipient who was receiving combination therapy with ganciclovir and foscarnet for treatment of viremia and retinitis. Analysis of sequential viral isolates recovered from the patient's cerebrospinal fluid suggested that disease developed because of the presence of viral resistance and, possibly, low tissue penetration of antiviral agents.


Subject(s)
Antiviral Agents/therapeutic use , Bone Marrow Transplantation/adverse effects , Cytomegalovirus Retinitis/virology , Cytosine/analogs & derivatives , Cytosine/therapeutic use , Drug Resistance, Viral , Encephalitis, Viral/virology , Foscarnet/therapeutic use , Ganciclovir/therapeutic use , Immunocompromised Host , Organophosphonates , Organophosphorus Compounds/therapeutic use , Cerebral Ventricles/virology , Child , Cidofovir , Cytomegalovirus Retinitis/drug therapy , Cytomegalovirus Retinitis/physiopathology , Drug Combinations , Drug Resistance, Viral/genetics , Encephalitis, Viral/drug therapy , Encephalitis, Viral/physiopathology , Female , Humans
19.
J Immunol ; 167(3): 1821-9, 2001 Aug 01.
Article in English | MEDLINE | ID: mdl-11466408

ABSTRACT

The exclusive detrimental role of proinflammatory cytokines in demyelinating diseases of the CNS, such as multiple sclerosis, is controversial. Here we show that the intrathecal delivery of an HSV-1-derived vector engineered with the mouse IFN-gamma gene leads to persistent (up to 4 wk) CNS production of IFN-gamma and inhibits the course of a chronic-progressive form of experimental autoimmune encephalomyelitis (EAE) induced in C57BL/6 mice by myelin oligodendrocyte glycoprotein (MOG)(35-55). Mice treated with the IFN-gamma-containing vector before EAE onset showed an earlier onset but a milder course of the disease compared with control mice treated with the empty vector. In addition, 83% of IFN-gamma-treated mice completely recovered within 25 days post immunization, whereas control mice did not recover up to 60 days post immunization. Mice treated with the IFN-gamma-containing vector within 1 wk after EAE onset partially recovered from the disease within 25 days after vector injection, whereas control mice worsened. Recovery from EAE in mice treated with IFN-gamma was associated with a significant increase of CNS-infiltrating lymphocytes undergoing apoptosis. During the recovery phase, the mRNA level of TNFR1 was also significantly increased in CNS-infiltrating cells from IFN-gamma-treated mice compared with controls. Our results further challenge the exclusive detrimental role of IFN-gamma in the CNS during EAE/multiple sclerosis, and indicate that CNS-confined inflammation may induce protective immunological countermechanisms leading to a faster clearance of encephalitogenic T cells by apoptosis, thus restoring the immune privilege of the CNS.


Subject(s)
Apoptosis/immunology , Brain/immunology , Cell Movement/immunology , Encephalomyelitis, Autoimmune, Experimental/immunology , Encephalomyelitis, Autoimmune, Experimental/prevention & control , Interferon-gamma/administration & dosage , Lymphocyte Subsets/pathology , Spinal Cord/immunology , Animals , Antigens, CD/biosynthesis , Apoptosis/genetics , Blood-Brain Barrier/genetics , Blood-Brain Barrier/immunology , Brain/metabolism , Brain/pathology , Cell Movement/genetics , Cerebral Ventricles/immunology , Cerebral Ventricles/virology , Chronic Disease , Cisterna Magna , Disease Progression , Encephalomyelitis, Autoimmune, Experimental/genetics , Encephalomyelitis, Autoimmune, Experimental/pathology , Female , Genetic Vectors/administration & dosage , Herpesvirus 1, Human/genetics , Injections , Injections, Spinal , Interferon-gamma/biosynthesis , Interferon-gamma/genetics , Lymphocyte Count , Lymphocyte Subsets/immunology , Lymphocyte Subsets/metabolism , Mice , Mice, Inbred C57BL , Receptors, Tumor Necrosis Factor/biosynthesis , Receptors, Tumor Necrosis Factor, Type I , Spinal Cord/metabolism , Spinal Cord/pathology , Subarachnoid Space/immunology , Subarachnoid Space/virology , Virus Replication/genetics
20.
Biologicals ; 27(1): 43-9, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10441402

ABSTRACT

Neurovirulence tests in Macaca fascicularis using commercial preparations of different vaccine bulks and a wild-type strain revealed that the test was unable to distinguish mixed from pure populations or a suitable vaccine from a related strain which has been shown to be associated with clinical meningitis. However, the test was able to distinguish a wild-type strain from the vaccine strains successfully. The ability of the test to discriminate between acceptable and unacceptable seeds requires further examination.


Subject(s)
Mumps Vaccine/standards , Animals , Body Weight/drug effects , Brain/pathology , Brain/virology , Cerebral Ventricles/pathology , Cerebral Ventricles/virology , Chlorocebus aethiops , Humans , Macaca fascicularis , Mumps Vaccine/administration & dosage , Mumps virus/pathogenicity , Serologic Tests , Severity of Illness Index , Vero Cells , Virulence
SELECTION OF CITATIONS
SEARCH DETAIL
...